Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for 4-aminoindan derivatives via reversed hydrogenation-acylation sequence, offering significant cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Novel patent CN118580192B details efficient chiral intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN102329281A details a novel asymmetric Steglich rearrangement for C-acyl azlactones, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Novel one-pot Ferrier rearrangement using FeCl3 catalyst. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Patent CN113999160B reveals a safer, cost-effective route for antiviral intermediates. Discover how this novel method reduces supply chain risks and manufacturing costs significantly.
Novel patent CN117886725A details a Pd-free synthesis route for apremilast intermediates, offering cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global buyers.
Patent CN100473642C details a 4-step asymmetric synthesis of alpha-alkyl-isoserine with 98% ee. Offers cost-effective routes for pharmaceutical intermediates.
Patent CN110563551A reveals gold-catalyzed route enhancing purity. Delivers supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN110563551A reveals a gold-catalyzed route for trans-2-ene-4-alkyne-1-alcohols. This method offers superior selectivity and safety for pharmaceutical intermediate manufacturing.
Patent CN113816913B reveals improved oxazepam intermediate synthesis with reduced waste and enhanced safety for reliable pharmaceutical intermediates supply chains.
Novel silver oxide rearrangement route reduces cost for pharmaceutical intermediates. Reliable supply chain for high-purity pyrimidine derivatives.
Novel patent CN103387565B enables cost-effective axitinib intermediate production with enhanced supply chain reliability and purity for global pharmaceutical manufacturers.
Novel semipinacol rearrangement route for high-purity chiral spiro ketones. Efficient scale-up for pharma intermediates and catalyst ligands.
Advanced patent-based synthesis of Cabazitaxel intermediates offering high yield and regioselectivity. Reliable supply chain solutions for complex anticancer drug manufacturing.
Patent CN102060731B reveals a cost-effective 3-step route for 2-acetamido-6-acetylphenol, offering significant supply chain advantages for Pranlukast manufacturing.
Patent CN102464626A details a safe, high-yield route for 5-(4-(N,N-diphenylamino)benzylidene)-3-(2-phenylethyl)-2,4-oxazolidinedione, offering significant cost and safety advantages for industrial supply chains.
Patent CN114524795A details a high-yield Rhodomyrtone synthesis eliminating column chromatography. Achieves 34.6% total yield and 99.8% purity for scalable API manufacturing.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Novel synthesis route for chiral aryl cyclopropyl amine derivatives. Enhances yield and scalability for Ticagrelor intermediate production. Reliable supply chain partner.